Assessment of health status by molecular measures in adults ranging from middle-aged to old: Ready for clinical use?

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Assessment of health status by molecular measures in adults ranging from middle-aged to old : Ready for clinical use? / Waaijer, M. E. C.; Westendorp, R. G. J.; Goldeck, D.; Gunn, D. A.; Pawelec, G.; Stijntjes, M.; Slagboom, P. E.; Maier, A. B.

In: Experimental Gerontology, Vol. 87, No. Part B, 01.2017, p. 175–181.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Waaijer, MEC, Westendorp, RGJ, Goldeck, D, Gunn, DA, Pawelec, G, Stijntjes, M, Slagboom, PE & Maier, AB 2017, 'Assessment of health status by molecular measures in adults ranging from middle-aged to old: Ready for clinical use?', Experimental Gerontology, vol. 87, no. Part B, pp. 175–181. https://doi.org/10.1016/j.exger.2016.03.020

APA

Waaijer, M. E. C., Westendorp, R. G. J., Goldeck, D., Gunn, D. A., Pawelec, G., Stijntjes, M., ... Maier, A. B. (2017). Assessment of health status by molecular measures in adults ranging from middle-aged to old: Ready for clinical use? Experimental Gerontology, 87(Part B), 175–181. https://doi.org/10.1016/j.exger.2016.03.020

Vancouver

Waaijer MEC, Westendorp RGJ, Goldeck D, Gunn DA, Pawelec G, Stijntjes M et al. Assessment of health status by molecular measures in adults ranging from middle-aged to old: Ready for clinical use? Experimental Gerontology. 2017 Jan;87(Part B):175–181. https://doi.org/10.1016/j.exger.2016.03.020

Author

Waaijer, M. E. C. ; Westendorp, R. G. J. ; Goldeck, D. ; Gunn, D. A. ; Pawelec, G. ; Stijntjes, M. ; Slagboom, P. E. ; Maier, A. B. / Assessment of health status by molecular measures in adults ranging from middle-aged to old : Ready for clinical use?. In: Experimental Gerontology. 2017 ; Vol. 87, No. Part B. pp. 175–181.

Bibtex

@article{9969c05f011047ac8611cc00de5c90a1,
title = "Assessment of health status by molecular measures in adults ranging from middle-aged to old: Ready for clinical use?",
abstract = "In addition to measures already used in clinical practice, molecular measures have been proposed to assess health status, but these have not yet been introduced into clinical practice. We aimed to test the association of functional capacity measures used in current practice and molecular measures with age and health status. The cohort consisted of 178 middle-aged to old participants of the Leiden Longevity Study (range 42-82years). We tested associations between functional capacity measures (physical tests: grip strength, 4-meter walk, chair stand test; cognitive tests: Stroop test, digit symbol substitution test and 15-picture learning test) with age and with cardiovascular or metabolic disease as a measure of the health status. These associations with age and health status were also tested for molecular measures (C reactive protein (CRP), numbers of senescent p16INK4a positive cells in the epidermis and dermis and putative immunosenescence (presence of CD57+ T cells)). All functional capacity measures were associated with age. CRP and epidermal p16INK4a positivity were also associated with age, but with smaller estimates. Grip strength and the Stroop test were associated with cardiovascular or metabolic disease, as was epidermal p16INK4a positivity. All associations with cardiovascular or metabolic disease attenuated when adjusting for age. In conclusion, in middle-aged to old persons, the molecular measures tested here were more weakly associated with age and health status than functional capacity measures. Whether these molecular measures associate more closely with health status in the elderly or in specific groups of patients needs to be explored further.",
author = "Waaijer, {M. E. C.} and Westendorp, {R. G. J.} and D. Goldeck and Gunn, {D. A.} and G. Pawelec and M. Stijntjes and Slagboom, {P. E.} and Maier, {A. B.}",
note = "Copyright {\circledC} 2015. Published by Elsevier Inc.",
year = "2017",
month = "1",
doi = "10.1016/j.exger.2016.03.020",
language = "English",
volume = "87",
pages = "175–181",
journal = "Experimental Gerontology",
issn = "0531-5565",
publisher = "Elsevier",
number = "Part B",

}

RIS

TY - JOUR

T1 - Assessment of health status by molecular measures in adults ranging from middle-aged to old

T2 - Ready for clinical use?

AU - Waaijer, M. E. C.

AU - Westendorp, R. G. J.

AU - Goldeck, D.

AU - Gunn, D. A.

AU - Pawelec, G.

AU - Stijntjes, M.

AU - Slagboom, P. E.

AU - Maier, A. B.

N1 - Copyright © 2015. Published by Elsevier Inc.

PY - 2017/1

Y1 - 2017/1

N2 - In addition to measures already used in clinical practice, molecular measures have been proposed to assess health status, but these have not yet been introduced into clinical practice. We aimed to test the association of functional capacity measures used in current practice and molecular measures with age and health status. The cohort consisted of 178 middle-aged to old participants of the Leiden Longevity Study (range 42-82years). We tested associations between functional capacity measures (physical tests: grip strength, 4-meter walk, chair stand test; cognitive tests: Stroop test, digit symbol substitution test and 15-picture learning test) with age and with cardiovascular or metabolic disease as a measure of the health status. These associations with age and health status were also tested for molecular measures (C reactive protein (CRP), numbers of senescent p16INK4a positive cells in the epidermis and dermis and putative immunosenescence (presence of CD57+ T cells)). All functional capacity measures were associated with age. CRP and epidermal p16INK4a positivity were also associated with age, but with smaller estimates. Grip strength and the Stroop test were associated with cardiovascular or metabolic disease, as was epidermal p16INK4a positivity. All associations with cardiovascular or metabolic disease attenuated when adjusting for age. In conclusion, in middle-aged to old persons, the molecular measures tested here were more weakly associated with age and health status than functional capacity measures. Whether these molecular measures associate more closely with health status in the elderly or in specific groups of patients needs to be explored further.

AB - In addition to measures already used in clinical practice, molecular measures have been proposed to assess health status, but these have not yet been introduced into clinical practice. We aimed to test the association of functional capacity measures used in current practice and molecular measures with age and health status. The cohort consisted of 178 middle-aged to old participants of the Leiden Longevity Study (range 42-82years). We tested associations between functional capacity measures (physical tests: grip strength, 4-meter walk, chair stand test; cognitive tests: Stroop test, digit symbol substitution test and 15-picture learning test) with age and with cardiovascular or metabolic disease as a measure of the health status. These associations with age and health status were also tested for molecular measures (C reactive protein (CRP), numbers of senescent p16INK4a positive cells in the epidermis and dermis and putative immunosenescence (presence of CD57+ T cells)). All functional capacity measures were associated with age. CRP and epidermal p16INK4a positivity were also associated with age, but with smaller estimates. Grip strength and the Stroop test were associated with cardiovascular or metabolic disease, as was epidermal p16INK4a positivity. All associations with cardiovascular or metabolic disease attenuated when adjusting for age. In conclusion, in middle-aged to old persons, the molecular measures tested here were more weakly associated with age and health status than functional capacity measures. Whether these molecular measures associate more closely with health status in the elderly or in specific groups of patients needs to be explored further.

U2 - 10.1016/j.exger.2016.03.020

DO - 10.1016/j.exger.2016.03.020

M3 - Journal article

C2 - 27045974

VL - 87

SP - 175

EP - 181

JO - Experimental Gerontology

JF - Experimental Gerontology

SN - 0531-5565

IS - Part B

ER -

ID: 160192137